- SGLT2 Inhibitor Use and Risk for ASCVD Events in Type 2 Diabetes
- Aspirin Use Associated With Reduced Mortality After ICU Stay
- FDA Approves Extended-Release Injection for Opioid Use Disorder
- US COVID-19 Hospitalizations Reach Record Low
- The Relationship Between Blood Pressure and Clinical Outcome After Stroke
- Continuous Glucose Monitoring and Hemoglobin A1c in Young Marginalized Patients
- Aromatherapy Improved Management of Chemotherapy-Induced Nausea and Vomiting
- Obesity Linked to Lower Short-Term Mortality in Patients With HF With Well-Nourished Status
- Women With Hypertensive Disorders of Pregnancy Benefit Most From Breastfeeding
- Fracture Risk Up With Prediabetes Before Menopause Transition
- Adverse Pregnancy Outcomes Increase Stroke Risk at an Earlier Age
- No Evidence OnabutulinumtoxinA Exposure in Pregnancy Ups Risk for Birth Defects
Clinical Tools
Powered by
Powered by 
Hypnosis or Mindful Meditation May Offer Relief From Acute Pain
Placebo Has Significant Pain Reduction Effect in Cannabinoid Clinical Trials
Pemafibrate and Cardiovascular Risk in Type 2 Diabetes
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
Does Ustekinumab or Vedolizumab Help Treat IBD Extraintestinal Manifestations?
